PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsWomen with a family history of breast cancer should take preventative drugs, says NICE

BioNews

Women with a family history of breast cancer should take preventative drugs, says NICE

Published 21 January 2013 posted in News and appears in BioNews 689

Author

Dr Lux Fatimathas

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Women at high risk of developing breast cancer should be offered preventative drugs, suggests the National Institute for Health and Clinical Excellence in updated guidelines...

Women at high risk of developing breast cancer should be offered preventative drugs, says an updated draft guideline from the National Institute for Health and Clinical Excellence (NICE).

'This draft guideline represents a historic step for the prevention of breast cancer. It is the first time drugs have ever been recommended for reducing breast cancer risk in the UK', says chief executive of the charity Breakthrough Breast Cancer, Chris Askew.

In the UK, breast cancer affects approximately 50,000 women a year, with ten percent of cases being familial. Familial breast cancer refers to cases where there is a strong family history of the disease, suggesting a genetic predisposition. Some genetic mutations are known to significantly increase the risk of developing breast cancer, such as mutations in the BRCA1 and BRCA2 genes.

'It's wise for any person with a family history of cancer to receive appropriate investigations and screening that would otherwise be unnecessary if a family history did not exist', says director of the Centre for Clinical Practice at NICE, Professor Mark Baker.

The guideline suggests women who are at high risk of familial breast cancer should be offered preventative treatment in the form of the drugs, tamoxifen or raloxifene, provided they do not have a history of blood clots or womb cancer. Different drug combinations are to be considered dependent on whether the women are pre- or post-menopausal. Based on evidence from recent studies, the drugs would be taken for a period of five years in order to decrease the likelihood of developing breast cancer. Tamoxifen and raloxifene are both hormone therapies currently used to treat breast cancer.

In the USA, the drugs have already been approved by the Food and Drug Administration for use in preventing breast cancer. However in the UK, they are not yet licensed for use in this context. They would therefore need to be prescribed 'off label' if there is 'good evidence to support that use', reports NICE.

Other suggestions by NICE include changes to the frequency of mammogram screening, which are currently offered every three years to women over the age of 50. For women who have not had breast cancer but are aged over 40 and at high risk, NICE suggests annual mammogram screening. For women who have had breast cancer and are at high risk of developing breast cancer again, annual MRI (magnetic resonance imaging) or mammogram testing was proposed, in addition to genetic testing for known mutations.

A spokeswoman from the Department of Health told the Guardian: 'This draft guidance will help healthcare professionals support the needs of their patients and we encourage organisations or individuals with an interest to give their feedback'.

The guidelines are still under consultation and are subject to change. The final version is expected to be published in June 2013.

Related Articles

PET BioNews
News
8 May 2017 • 2 minutes read

New approach to tackle breast cancer

by Dr Jamie Heather

Researchers have discovered a new approach to slow the rate of breast cancer tumour growth in mice...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 November 2013 • 2 minutes read

Breast cancer risk may still be higher despite BRCA-negative test results

by Dr Charlotte Warren-Gash

Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 September 2013 • 3 minutes read

Gene test to determine breast cancer treatment gets approval

by David Gerard O'Rourke

A new genetic test that can estimate the risk of breast cancer in women returning after surgery has been approved for use in the NHS....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
27 August 2013 • 5 minutes read

Radio Review: Inside the Ethics Committee - Genetic Testing in Children

by Clara Salice

In this episode of Radio 4's Inside the Ethics Committee, we hear about Rachel's strong desire for her children to be tested for an inherited disease, Li-Fraumeni syndrome...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 March 2013 • 2 minutes read

Two gene variants linked to breast size also linked to breast cancer

by Ruth Saunders

Two novel gene variants linked to breast size may also also influence the risk of breast cancer, according to a study carried out by US genetics company 23andMe....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 February 2013 • 2 minutes read

Genetics of breast cancer progression mapped

by Rebecca Hill

The genetic landscape of breast cancer is much more complicated than previously hoped, according to the authors of two analyses of multiple tumour genomes...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 February 2013 • 2 minutes read

Genetic test could identify breast cancer risk

by Dr Kimberley Bryon-Dodd

A link between modifications to a white blood cell gene and an increased risk of breast cancer could be the basis for a simple blood test to identify women most at risk of developing the disease...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 December 2012 • 1 minute read

Mammograms may increase risk of breast cancer in some women

by Daryl Ramai

Women carrying mutations in their BRCA genes may be more susceptible to breast cancer if exposed to diagnostic chest X-rays before the age of 30, say scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 September 2012 • 2 minutes read

Genetic similarities found between ovarian and breast cancers

by Zara Mahmoud

Scientists have found molecular similarities between a subtype of breast cancer and a hard-to-treat form of ovarian cancer...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Twenty-five genetic variants for autism discovered

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856